Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 67351 - 67375 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Rosiglitazone	Approved Investigational	VNN1	8876	upregulated	rosiglitazone results in increased expression of VNN1 mRNA	6q23.2	A22609
Rosiglitazone	Approved Investigational	VPS37D	155382	downregulated	rosiglitazone results in decreased expression of VPS37D mRNA	7q11.23	A22609
Rosiglitazone	Approved Investigational	VWCE	220001	downregulated	rosiglitazone results in decreased expression of VWCE mRNA	11q12.2	A20427
Rosiglitazone	Approved Investigational	WDR12	55759	upregulated	rosiglitazone results in increased expression of WDR12 mRNA	2q33.2	A22609
Rosiglitazone	Approved Investigational	WDR7	23335	downregulated	rosiglitazone results in decreased expression of WDR7 mRNA	18q21.31	A20427
Rosiglitazone	Approved Investigational	WDR72	256764	downregulated	rosiglitazone results in decreased expression of WDR72 mRNA	15q21.3	A22609
Rosiglitazone	Approved Investigational	WFS1	7466	upregulated	rosiglitazone results in increased expression of WFS1 mRNA	4p16.1	A10216
Rosiglitazone	Approved Investigational	WWC2	80014	downregulated	rosiglitazone results in decreased expression of WWC2 mRNA	4q35.1	A20427
Rosiglitazone	Approved Investigational	XIAP	331	downregulated	rosiglitazone results in decreased expression of XIAP mRNA	Xq25	A24105 A24106
Rosiglitazone	Approved Investigational	ZBTB7B	51043	downregulated	rosiglitazone results in decreased expression of ZBTB7B mRNA	1q21.3	A10216
Rosuvastatin	Approved Investigational	ABCA1	19	downregulated	Rosuvastatin Calcium results in decreased expression of ABCA1 mRNA	9q31.1	A24148
Rosuvastatin	Approved Investigational	ABCG1	9619	downregulated	Rosuvastatin Calcium results in decreased expression of ABCG1 mRNA	21q22.3	A24148
Rosuvastatin	Approved Investigational	CREB5	9586	downregulated	Rosuvastatin Calcium results in decreased expression of CREB5 mRNA	7p15.1-p14.3	A24148
Rosuvastatin	Approved Investigational	GCLC	2729	upregulated	Rosuvastatin Calcium results in increased expression of GCLC mRNA	6p12.1	A24149
Rosuvastatin	Approved Investigational	GZMK	3003	upregulated	Rosuvastatin Calcium results in increased expression of GZMK mRNA	5q11.2	A24148
Rosuvastatin	Approved Investigational	IL18RAP	8807	downregulated	Rosuvastatin Calcium results in decreased expression of IL18RAP mRNA	2q12.1	A24148
Rosuvastatin	Approved Investigational	KCNJ15	3772	downregulated	Rosuvastatin Calcium results in decreased expression of KCNJ15 mRNA	21q22.13-q22.2	A24148
Rosuvastatin	Approved Investigational	ORM1	5004	downregulated	Rosuvastatin Calcium results in decreased expression of ORM1 mRNA	9q32	A24148
Rosuvastatin	Approved Investigational	PI3	5266	downregulated	Rosuvastatin Calcium results in decreased expression of PI3 mRNA	20q13.12	A24148
Rosuvastatin	Approved Investigational	VNN3	55350	downregulated	Rosuvastatin Calcium results in decreased expression of VNN3 mRNA	6q23.2	A24148
Rotenone	Experimental Vet Approved	APAF1	317	upregulated	Rotenone results in increased expression of APAF1 mRNA alternative form	12q23.1	A24150
Rotenone	Experimental Vet Approved	ARL2	402	downregulated	Rotenone results in decreased expression of ARL2 mRNA	11q13.1	A24151
Rotenone	Experimental Vet Approved	ATF4	468	upregulated	Rotenone results in increased expression of ATF4 mRNA	22q13.1	A24152
Rotenone	Experimental Vet Approved	ATM	472	upregulated	Rotenone results in increased expression of ATM mRNA	11q22.3	A24153
Rotenone	Experimental Vet Approved	ATP5E	514	upregulated	Rotenone results in increased expression of ATP5E mRNA	20q13.32	A24153

Displaying entries 67351 - 67375 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability